Plasma cell myeloma masquerading as scleromyxedema
Scleromyxedema is a rare progressive cutaneous mucinosis of unknown etiology with equal prevalence in both men and women. It is usually associated with monoclonal gammopathy in most of the cases. Various treatment modalities have been tried for scleromyxedema including steroids, intravenous immunogl...
Main Authors: | Varun Victor, Rashmi Maria Margareat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Dermatology Online Journal |
Subjects: | |
Online Access: | http://www.idoj.in/article.asp?issn=2229-5178;year=2019;volume=10;issue=1;spage=50;epage=53;aulast=Victor |
Similar Items
-
Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
by: Sara Saniee, et al.
Published: (2016-11-01) -
Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
by: Hninyee Win, et al.
Published: (2020-12-01) -
Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
by: Taleb Azarm, et al.
Published: (2012-01-01) -
Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma
by: Laura Rosiñol, et al.
Published: (2023-11-01) -
Scleromyxedema, a therapeutic dilemma
by: Julio Cesar Salas-Alanis, et al.
Published: (2015-01-01)